The levels of CD1d on monocytes remained lower in CR-AML patients than in the healthy controls (P<0.0.5; Table II and Fig. 1E and G), while the levels of CD1d on monocytes recovered in the CR-ALL patients (P>0.0.5; Table II and Fig. 1F and G). This evidence concerns the gene CD1D and acute myeloid leukemia.